Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
HOS 2018: Scientific Program
Share |


Scientific program coming soon!   



 

Keynote Speakers

Manipulating Protein Structure For Therapeutic Utility (Engineering For Properties That Mother Nature Never Had To Consider)
John Beals, Eli Lilly and Company

Approaches and Challenges for Quantifying Multi-body Interactions as Higher-order Structure for Key Product Attributes
Chris Roberts, University of Delaware 

 

Session Speakers

Application of HDX-MS to Biopharmaceutical Development Requirements: Improved Sensitivity to Detection of Conformational Changes
Lea Bonnington, F. Hoffmann - La Roche Ltd

Linking Structure to Function, Criticality Assessment of Thiol-Related Variants in Therapeutic mAbs
Yan Chen, Genentech, a Member of the Roche Group

Immunogenicity of Protein Aggregates: What’s New?
Wim Jiskoot, University of Utrecht

Seeing Is Believing: How We Use Single-molecule 3D Image to Understand pH-dependent HOS Change in a IgG1 Homodimer
Ming Lei, Genentech, a Member of the Roche Group

Leveraging X-ray Crystallography for Biosimilarity Assessment
Tom Lerch, Pfizer, Inc.

Identifying HOS Variation with Multivariate Analysis of 2D NMR
John Marino, NIST

Approaches and Challenges for Quantifying Multi-body Interactions as Higher-order Structure for Key Product Attributes
Chris Roberts, University of Delaware

Computational Approaches for Assessing Developability and Optimization of Biotherapeutics
Nels Thorsteinson, Chemical Computing Group

 

 



more Calendar

12/4/2017 » 12/5/2017
CMC Strategy Forum Japan 2017

Featured Members
Jamie Moore, Genentech, a Member of the Roche GroupVisit the CASSS News page to get to know Jamie Moore!

Membership Software Powered by YourMembership  ::  Legal